Caesars Entertainment Friday announced the appointment of Sandra Douglass Morgan as the tenth member of its board of directors.
Morgan formerly served as chairwoman of the Nevada Gaming Control Board in 2019, the first Black to serve as chair, and the second woman.
“Sandra is rooted in the gaming industry in a way few others could be,” said Caesars Entertainment Executive Chairman of the Board Gary Carano in a statement. “Her experience as chair of the Nevada Gaming Control Board and as a member of the Nevada Gaming Commission gives her a deep understanding of our industry. Her leadership as an attorney for gaming corporations and government entities adds another lens through which she has developed a unique perspective which will help our company continue to move forward as the gaming landscape evolves and grows.”
Before serving on the NGCB, Morgan was director of external affairs for AT&T Services, responsible for managing the company’s government and community affairs in Nevada. She previously was the city attorney for the City of North Las Vegas, the first Black city attorney in Nevada. A Las Vegas native, Morgan also was a litigation attorney for MGM Mirage (now MGM Resorts International).
With the NGCB, Morgan’s accomplishments included ensuring licensees adopted and implemented policies against discrimination. She also helped pave the way for cashless wagering at machines and table games and guided the agency through the start of the COVID-19 pandemic.
Morgan currently serves as a board member of publicly traded companies Fidelity National Financial, Allegiant Travel Company, and Cerberus Cyber Sentinel Corp.
“Sandra is a proven leader, team builder, and passionate advocate for always doing the right thing,” said Caesars Entertainment CEO Tom Reeg, in a statement. “I’m pleased to add her independent voice to our strong board of directors. I look forward to working with her, the rest of our board, and the management team to continue to drive results for our guests, our team members, and our shareholders.”
Morgan’s appointment is effective November 7 and subject to required regulatory approvals.
